Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Omalizumab can cause temporary hair loss but still works well for chronic urticaria.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Targeted cancer therapies can cause new side effects, requiring careful monitoring and management to ensure patient safety.

PPX causes much less hair loss than traditional taxanes.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Topical vasoconstrictors do not reduce chemotherapy effectiveness against leukemia in mice.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

Upadacitinib effectively treats pyoderma gangrenosum.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

A special gel with medicine helps prevent melanoma from coming back after surgery.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.